Electron arc irradiation of the postmastectomy chest wall: Clinical results

被引:29
作者
Gaffney, DK
Prows, J
Leavitt, DD
Egger, MJ
Morgan, JG
Stewart, JR
机构
[1] METHODIST HOSP,MIDWEST RADIAT ONCOL CLIN,OMAHA,NE
[2] UNIV UTAH,HLTH SCI CTR,DEPT FAMILY & PREVENT MED,SALT LAKE CITY,UT 84132
关键词
breast cancer; postmastectomy; chest wall; electron arc; rotational therapy;
D O I
10.1016/S0167-8140(96)01860-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Since 1980 electron are irradiation of the postmastectomy chest wall has been the preferred technique for patients with advanced breast cancer at our institution. Here we report the results of this technique in 140 consecutive patients treated from 1980 to 1993. Materials and Methods: Thoracic computerized tomography was used to determine internal mammary lymph node depth and chest wall thickness, and for computerized dosimetry calculations. Total doses of 45-50 Gy in 5 to 5 1/2 weeks were delivered to the chest wall and internal mammary lymph nodes via electron are and, in most cases, supraclavicular and axillary nodes were treated with a matching photon field. Patients were assessed for acute and late radiation changes, local and distant control of disease, and survival. Patients had a minimum follow-up of 1 year after completion of radiation treatment, and a mean follow up interval of 49 months and a median of 33 months. All patients had advanced disease: T stages 1, 2, 3, and 4 represented 21%, 39%, 21% and 19% of the study population, with a mean number of positive axillary lymph nodes of 6.5 (range, 0-29). Analysis was performed according to adjuvant status (no residual disease, n=90), residual disease (positive margin, n=15, and primary radiation, n=2), or recurrent disease (n=33). Results: Acute radiation reactions were generally mild and self limiting. A total of 26% of patients developed moist desquamation, and 32% had brisk erythema. Actuarial 5 year local-regional control, freedom from distant failure, and cause-specific survival was 91%, 64%, and 75% in the adjuvant group; 84%, 50%, and 53% in the residual disease group; and 63%, 34%, and 32% in the recurrent disease group, respectively. In univariate Cox regressions, the number of positive lymph nodes was predictive for local failure in the adjuvant group (P=0.037). Chronic complications were minimal with 11% of patients having arm edema, 17% hyperpigmentation, and 13% telangectasia formation. Conclusion: These data demonstrate that local-regional control with electron are therapy of the postmastectomy chest wall is comparable to photon techniques. Acute radiation reactions are well tolerated and mostly of minor extent. A previous report demonstrated a significant reduction in the dose-volume relationship of the lung using the electron are compared with two photon techniques. Consequently, with careful attention to treatment planning and dosimetry, electron are therapy of the postmastectomy chest wall is safe and effective. The radiation dose to heart and lung is minimized without compromise on local control. (C) 1997, Elsevier Science Ireland Ltd.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 41 条
[1]   A PRELIMINARY ASSESSMENT OF FACTORS ASSOCIATED WITH RECURRENT DISEASE IN A SURGICAL ADJUVANT CLINICAL-TRIAL FOR PATIENTS WITH BREAST-CANCER WITH SPECIAL EMPHASIS ON THE AGGRESSIVENESS OF THERAPY [J].
AHMANN, DL ;
OFALLON, JR ;
SCANLON, PW ;
PAYNE, WS ;
BISEL, HF ;
EDMONSON, JH ;
FRYTAK, S ;
HAHN, RG ;
INGLE, JN ;
RUBIN, J ;
CREAGAN, ET .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04) :371-381
[2]  
[Anonymous], DIS BREAST
[3]   PATHOPHYSIOLOGY OF IRRADIATED SKIN AND BREAST [J].
ARCHAMBEAU, JO ;
PEZNER, R ;
WASSERMAN, T .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1171-1185
[4]   LONG-TERM EFFECT OF INTERNAL MAMMARY CHAIN TREATMENT - RESULTS OF A MULTIVARIATE-ANALYSIS OF 1195 PATIENTS WITH OPERABLE BREAST-CANCER AND POSITIVE AXILLARY NODES [J].
ARRIAGADA, R ;
LE, MG ;
MOURIESSE, H ;
FONTAINE, F ;
DEWAR, J ;
ROCHARD, F ;
SPIELMANN, M ;
LACOUR, J ;
TUBIANA, M ;
SARRAZIN, D .
RADIOTHERAPY AND ONCOLOGY, 1988, 11 (03) :213-222
[5]   ADEQUATE LOCOREGIONAL TREATMENT FOR EARLY BREAST-CANCER MAY PREVENT SECONDARY DISSEMINATION [J].
ARRIAGADA, R ;
RUTQVIST, LE ;
MATTSSON, A ;
KRAMAR, A ;
ROTSTEIN, S .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2869-2878
[6]   RADIOTHERAPY ALONE IN BREAST-CANCER - ANALYSIS OF TUMOR AND LYMPH-NODE RADIATION-DOSES AND TREATMENT-RELATED COMPLICATIONS - THE EXPERIENCE OF THE GUSTAVE-ROUSSY-INSTITUTE AND THE PRINCESS-MARGARET-HOSPITAL [J].
ARRIAGADA, R ;
MOURIESSE, H ;
REZVANI, A ;
SARRAZIN, D ;
CLARK, RM ;
DEBOER, G ;
BUSH, RS .
RADIOTHERAPY AND ONCOLOGY, 1993, 27 (01) :1-6
[7]   ANALYSIS OF COSMETIC RESULTS AND COMPLICATIONS IN PATIENTS WITH STAGE-I AND STAGE-II BREAST-CANCER TREATED BY BIOPSY AND IRRADIATION [J].
CLARKE, D ;
MARTINEZ, A ;
COX, RS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (12) :1807-1813
[8]  
CUZICK J, 1987, CANCER TREAT REP, V71, P15
[9]   CAUSE-SPECIFIC MORTALITY IN LONG-TERM SURVIVORS OF BREAST-CANCER WHO PARTICIPATED IN TRIALS OF RADIOTHERAPY [J].
CUZICK, J ;
STEWART, H ;
RUTQVIST, L ;
HOUGHTON, J ;
EDWARDS, R ;
REDMOND, C ;
PETO, R ;
BAUM, M ;
FISHER, B ;
HOST, H ;
LYTHGOE, J ;
RIBEIRO, G ;
SCHEURLEN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :447-453
[10]  
Dixon WJ, 1990, BMDP STAT SOFTWARE